Drug Shortage Report for MILRINONE LACTATE INJECTION, USP
Report ID | 2996 |
Drug Identification Number | 02244622 |
Brand name | MILRINONE LACTATE INJECTION |
Common or Proper name | Milrinone Lactate Injection 1 mg/mL SD Vial 20 mL |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | MILRINONE |
Strength(s) | 1.0MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 20mL |
ATC code | C01CE |
ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-03-20 |
Actual start date | |
Estimated end date | |
Actual end date | 2017-04-07 |
Shortage status | Resolved |
Updated date | 2017-04-08 |
Company comments | Available at all locations Friday April 7th. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2017-04-08 | English | Compare |
v7 | 2017-04-05 | French | Compare |
v6 | 2017-04-05 | English | Compare |
v5 | 2017-04-05 | English | Compare |
v4 | 2017-03-21 | English | Compare |
v3 | 2017-03-15 | French | Compare |
v2 | 2017-03-15 | English | Compare |
v1 | 2017-03-15 | English | Compare |
Showing 1 to 8 of 8